
Duchenne muscular dystrophy changes how force is transmitted through muscle tissue. Using a multiscale muscle modeling framework, FilamenTech examined how the lack of dystrophin affects extracellular matrix deformation between fast and slow muscle fibers.
This case study extends FilamenTech’s platform logic beyond cardiac muscle, showing how mechanistic modeling can reveal tissue-level consequences of molecular defects in Duchenne muscular dystrophy.
Reference:
Prodanovic et al., BIBE 2021




Human cardiac prediction from data you already have.
FilamenTech develops multiscale mechanistic simulation workflows that help drug-development teams translate assay, tissue, animal, mutation, and structural data into human-relevant cardiac and muscle predictions.
Boston • Belgrade
Start with a focused pilot.
Evaluate mutation effects, drug responses, or translational hypotheses using mechanistic simulation workflows tailored to your program.
© 2026 FilamenTech. All rights reserved.
Created by Starter studio.